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Paenibacillus polymyxa PKB1 produces fusaricidins,
a family of lipopeptide antibiotics that strongly in-
hibits the growth of many plant pathogenic fungi.
The fusaricidin biosynthetic gene cluster was cloned
and sequenced, and it spans 32.4 kb, including an
open reading frame (fusA) encoding a six-module
nonribosomal peptide synthetase. The second,
fourth, and fifth modules of fusaricidin synthetase
each contain an epimerization domain, consistent
with the structure of fusaricidins. However, no epi-
merization domain is found in the sixth module, cor-
responding to D-Ala. This sixth adenylation domain
was produced at a high level in Escherichia coli and
is shown to activate D-Ala specifically, providing
evidence for direct activation of a D-amino acid by a
prokaryotic peptide synthetase. The fusaricidin gene
cluster also includes genes involved in the biosyn-
thesis of the lipidmoiety, but no genes for resistance,
regulation, or transport functions were encountered.
INTRODUCTION
Fusaricidins are a group of lipopeptide antibiotics produced by
Paenibacillus polymyxa (formerly Bacillus polymyxa) and consist
of a guanidinylated b-hydroxy fatty acid linked to a cyclic hexa-
peptide including four amino acid residues in the D-configuration
(Figure 1) (Nakajima et al., 1972; Kurusu et al., 1987; Kajimura
and Kaneda, 1996, 1997; Kuroda et al., 2000). The antifungal ac-
tivity of the fusaricidins against Leptosphaeria maculans, a plant
pathogenic fungus causing phoma stem canker (blackleg) dis-
ease in canola,makesP. polymyxaPKB1of interest as a potential
agent for biocontrol of blackleg disease (Kharbanda et al., 1997;
Beatty and Jensen, 2002). Previously, we identified a fragment of
a peptide synthetase gene (fusA) involved in the nonribosomal
biosynthesis of fusaricidins (Li et al., 2007). Nonribosomal pep-
tide synthetases (NRPSs) are large multienzyme complexes
that are organized into modules (Marahiel et al., 1997). The num-
ber and order of modules are usually colinear with the amino acid
sequence of the peptide product. Modules can be further di-
vided into domains, each responsible for one catalytic step of
peptide synthesis. The adenylation (A) domain is responsible
for substrate recognition and activation as an aminoacyl adeny-118 Chemistry & Biology 15, 118–127, February 2008 ª2008 Elsevielate. The activated amino acid is subsequently transferred to
a 40-phosphopantetheine (40-PP) cofactor that is covalently teth-
ered to the T domain, located downstream of the A domain. The
condensation (C) domain, located between the T and A domains
of consecutive modules, catalyzes peptide bond formation be-
tween two adjacent substrates. Finally, the fully assembled pep-
tide chain is released from the enzyme template through cycliza-
tion or hydrolysis, which is typically carried out by a thioesterase
(TE) domain located at the C-terminal end of the last module,
although in some instances a reductase domain can also be
responsible for release and cyclization (Kessler et al., 2004;
Kopp et al., 2006).
Unlike ribosomally synthesized peptides and proteins, a com-
mon structural feature of nonribosomal peptides is the incorpo-
ration of nonproteinogenic amino acid residues, which dramati-
cally increases the structural diversity and biological activity of
peptides made by NRPSs. These nonproteinogenic residues in-
clude D-amino acids, and three different mechanisms of D-amino
acid incorporation have been encountered to date. In most pep-
tide synthetases, modules that incorporate D-configured resi-
dues contain an additional domain responsible for epimerization,
found downstream of the T domain. An L-amino acid is acti-
vated, and the epimerization (E) domain then catalyzes L-to-D ra-
cemization of the thioester-bound amino acid (Stachelhaus and
Walsh, 2000). A second mechanism for incorporating D-amino
acids was observed in several NRPSs isolated from both actino-
mycete and Pseudomonas strains (Guenzi et al., 1998; McCaff-
erty et al., 2002; Roongsawang et al., 2003; Scholz-Schroeder
et al., 2003; Balibar et al., 2005; Yin and Zabriskie, 2006). In
the lipopeptide arthrofactin, for example, there are no E domains
detected in any of the 3 arthrofactin synthetases, although 7 of
the 11 amino acids are in the D-configuration. Biochemical anal-
yses demonstrated that A domains in modules corresponding to
D-amino acids were specific for activation of L-isomers, and
epimerase activity was provided by a new type of C domain
with dual epimerization and condensation functions, located
downstream of the T domain acylatedwith the amino acid under-
going epimerization. A third, very rare strategy for incorporation
of D-amino acids involves the direct activation of D-isomers by
the A domains. This mechanism was originally encountered in
cyclosporin (Dittmann et al., 1994; Weber et al., 1994) and HC-
toxin synthetases (Walton, 1987; Scott-Craig et al., 1992), both
from fungal systems. Although these NRPSs purified from natu-
ral sources were shown convincingly to incorporate D-Ala, no
biochemical studies with recombinant A domains have yet
been conducted. Both gene clusters encode independentr Ltd All rights reserved
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et al., 1994; Cheng and Walton, 2000). Very recently, a third ex-
ample of direct activation of a D-amino acid was reported in
Streptomyces atroolivaceus, producer of the antitumor agent lei-
namycin. Leinamycin is a hybrid peptide/polyketide product in
which a D-Ala residue serves as a starter unit for assembly of
the molecule. The D-Ala residue is activated for this purpose by
means of an isolated adenylation protein, and the specificity of
this protein was shown to be for D- rather than L-Ala (Tang
et al., 2007). Finally, the D-alanylation of lipoteichoic acids in Ba-
cillus subtilis involves a D-alanyl-D-alanine carrier protein ligase
that appears to activate D-alanine directly by a mechanism sim-
ilar to that seen in the nonribosomal peptide synthatases (Perego
et al., 1995).
In this study, we cloned and characterized the complete fusar-
icidin biosynthetic gene cluster from P. polymyxa PKB1, includ-
ing fusA, which encodes a single peptide synthetase enzyme in-
volved in fusaricidin biosynthesis. Substrate specificity of the A
domain from the sixth module was investigated, and D-Ala was
shown to be activated directly, providing clear evidence of direct
selection and activation of a D-amino acid in a typical prokaryotic
NRPS system.
RESULTS AND DISCUSSION
Cloning and Sequencing the Fusaricidin Biosynthetic
Gene Cluster, fus
Previously, we constructed a SuperCos-1 genomic library of P.
polymyxa PKB1, and isolated a cosmid, Col-19, carrying a partial
Figure 1. Structure of Fusaricidin C
Amino acid substitutions tolerated at three defined positions in fusaricidin var-
iants are also presented. Residues are numbered according to the order of
synthesis.Chemistry & Biology 15ORF (designated fusA) that encodes two modules typical of
NRPSs (Li et al., 2007). Disruption of fusA completely abolished
the antifungal activity of strain PKB1, indicating that it is part of
the fusaricidin biosynthetic gene cluster (fus). However, addi-
tional sequence analysis of Col-19 indicated that rearrangement
of the insert DNA or incorporation of non-contiguous genomic
DNA fragments had occurred, preventing complete analysis of
the fus gene cluster. A second SuperCos-1 genomic library of
PKB1 showed similar defects in all fusA-bearing clones, despite
careful attention to size selection of insert DNA fragments during
library construction. To circumvent these apparent instability
problems, a third genomic library of PKB1 was constructed by
using pSMART-FOS, a single-copy fosmid vector designed for
the stable maintenance of DNA inserts. The fosmid library was
screened by using a probe derived from the 30 end of the previ-
ously sequenced fusA gene fragment, and two overlapping fos-
mids, 4G9 and 6D11, were selected from a group of positive
clones for further study. Southern analyses showed no evidence
of rearrangement of the fosmid insert DNA, and sequence anal-
ysis yielded48 kb of contiguous DNA sequence information
(Figure 2A). Subsequent analyses suggest that this DNA se-
quence covers the entire fusaricidin biosynthetic gene cluster
as well as flanking regions, although definitive proof would
require heterologous expression of the entire gene cluster.
Overall Organization of the fus Gene Cluster
The fus gene cluster itself covers 32.4 kb and includes 8 ORFs.
The organization and assigned functions of these ORFs are
shown in Figure 2A and Table 1, respectively. The boundaries
of the fus cluster are predicted based on the nature of the
gene products encoded and on gene-disruption analyses.
Genes identified in the biosynthetic gene cluster include those
necessary for assembly of the peptide backbone as well as syn-
thesis and incorporation of the lipid moiety, but genes for regu-
lation, export, and resistance were not detected in the region.
Modular Organization of the Fusaricidin Synthetase
The fus gene cluster includes a large ORF of about 23.7 kb, en-
coding a protein of 7,908 amino acids with a molecular mass of
888,101 Da. The predicted gene product shows the highest sim-
ilarity to bacitracin synthetase (BacC) fromBacillus licheniformis.
Sequence analysis revealed that the partial ORF cloned previ-
ously (Li et al., 2007) corresponds to the 50 end of this NRPS
gene. Therefore, we have retained the designation for the com-
plete ORF as the fusaricidin synthetase gene, fusA. The transla-
tion of fusA appears to start with an ATG codon at nt 17,682 of
the deposited sequence, 7 bp downstream of a putative ribo-
some-binding site (50-AGGAGT-30). By comparison with other
peptide synthetases, six functional modules were identified
within the deduced amino acid sequence of FusA (Figure 2B).
Each module contains the three catalytic domains common to
NRPSs, an A, a T, and a C domain.
FusA contains five typical C domains that presumably catalyze
peptide bond formation between the adjacent amino acid resi-
dues of fusaricidin. An additional C domain was detected at
the N terminus of the first module of FusA. C domains are not
normally present in the initial modules of NRPSs, except for in lip-
opeptides and chromodepsipeptides, subgroups of nonriboso-
mal peptides with acyl groups and chromophores, respectively,, 118–127, February 2008 ª2008 Elsevier Ltd All rights reserved 119
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Fusaricidin Biosynthesis in P. polymyxaFigure 2. Diagrammatic Representation of the Fusaricidin Biosynthetic Gene Cluster
(A) ORF arrangement of the fus gene cluster and flanking regions. The black arrow represents the peptide synthetase gene fusA, whereas other fusaricidin
biosynthetic genes are shown in gray; genes flanking the cluster are in white. The overlapping fosmid inserts cloned in this study are also shown.
(B) Module and domain organization of the fusaricidin synthetase encoded by fusA.attached at the N terminus (Schmoock et al., 2005). The pres-
ence of N-terminal C domains (CN) has been reported for a num-
ber of lipopeptide synthetases, including those from actinomy-
cete, Bacillus, and Pseudomonas species (Guenzi et al., 1998;
Roongsawang et al., 2003; Cosmina et al., 1993; Duitman
et al., 1999; Konz et al., 1999; Lin et al., 1999; Tsuge et al.,
2001; Miao et al., 2005, 2006) and is suggested to catalyze acyl-
ation of the first amino acid with a fatty acid as an early step
of lipopeptide biosynthesis. Since they catalyze the coupling of
fatty acids rather than amino acids to the first amino acid of
the peptide chain, these initial C domains may share structural
features not found in regular C domains, which could explain
the greater similarity seen among C domains from within this
group than to other typical C domains (Figure 3). The remaining
five C domains in FusA can be subdivided into two groups ac-
cording to their locations: they are the CD domains (in FusA-
C3, FusA-C5, and FusA-C6), which are preceded by an E domain
and accept an upstream D-amino acid at the donor site, and CL
domains (in FusA-C2 and FusA-C4), which are located immedi-
ately downstream of a T domain and accept an upstream
L-amino acid at the donor site. Distinct differences between the
CD and CL domains and similarities within the same domain
type were seen in the amino acid sequences of the conserved
motifs. This may reflect the stereoselectivity of C domains120 Chemistry & Biology 15, 118–127, February 2008 ª2008 Elsevietoward the C-terminal amino acid of the growing peptidyl chain
in the course of the condensation reaction.
Modifying E domains were detected at the C-terminal ends of
the second, fourth, and fifth modules, consistent with the incor-
poration of D-amino acids in these positions of fusaricidin pep-
tides. However, the sixth module, FusA-M6, corresponding to
D-Ala, lacks such an E domain, and instead terminates with
a C-terminal TE domain responsible for the cyclization and
release of the peptide product.
The T domains upstream of the E domains in FusA-M2, FusA-
M4, and FusA-M5 all contain a core sequence of LGGDSIK. The
aspartate residue (in bold) in front of the conserved serine resi-
due is essential for proper interaction between the T domain
and the downstream E domain, and subsequent racemization
of the thioester bound L-amino acid to its D-isomer (Linne et al.,
2001). In contrast, the core sequence of the T domain found in
FusA-M6 (LGGHSL) matches that of T domains not associated
with E domains (xGGHSL), such as those found in the first and
third modules. This finding is consistent with the absence of an
E domain in the final module of FusA. Furthermore, since the
amino acid activated by FusA-M6 occupies the C-terminal posi-
tion of the fusaricidin peptide, this excludes the possibility that
epimerization of an L-Ala residue is catalyzed by a downstream
dual C/E domain, as seen in some pseudomonads andr Ltd All rights reserved
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ORF Gene
Nucleotide
Position Highest BLAST Hit (%Identity/%Similarity)
1 gat 853–1428 Glutamine amidotransferase of anthranilate synthase (Thiobacillus denitrificans) YP_315982 (72/87)
2 adl 1432–2328 4-amino-4-deoxychorismate lyase (Bacillus sp.) ZP_01173359 (51/61)
3 dps 2361–3191 Dihydropteroate synthase (Geobacillus kaustophilus) YP_145922 (64/76)
4 dna 3390–3752 Dihydroneopterin aldolase (Bacillus coagulans) ZP_01697879 (54/75)
5 hpk 3762–4310 2-amino-4-hydroxy-6-hydroxymethyldihydropteridine pyrophosphokinase (Bacillus cereus)
ZP_00240852 (50/67)
6 xre 4271–4462 Probable transcriptional regulator (Bacillus sp.) ZP_01173355 (50/71)
7 dus 4508–5536 tRNA-dihydrouridine synthase (Bacillus clausii) YP_173620 (74/88)
8 greA 5730–6227 Transcription elongation factor (Pelotomaculum thermopropionicum) YP_001210812 (71/87)
9 lysRS 6338–7858 Lysyl-tRNA synthetase (Geobacillus kaustophilus) YP_145927 (74/86)
10 ktp 7949–9286 K+ uptake transporter (Trk family) (Geobacillus kaustophilus) YP_146065 (48/71)
11 ymcC 9579–10112 YmcC (unknown function) (Rubrobacter xylanophilus) YP_645537 (49/68)
12 fusG 10739–11473 Enoyl-(acyl carrier protein) reductase (Bacillus cereus) NP_977660 (62/79)
13 fusF 11534–12946 Acyl CoA ligase (Streptomyces aizunensis) AAX98201 (36/56)
14 fusE 12991–14214 Hypothetical protein (aldehyde dehydrogenase) (Saccharopolyspora erythraea) YP_001102874 (40/65)
15 fusD 14211–15911 Acetolactate synthase large subunit (Saccharopolyspora erythraea)YP_001102875 (42/62)
16 fusC 16118–17176 3-oxoacyl-(acyl carrier protein) synthase (Bacillus licheniformis)YP_078422 (54/74)
17 fusB 17181–17588 (3R)-hydroxymyristoyl-[acyl carrier protein] dehydratase (Bacillus cereus) NP_832645 (48/75)
18 fusA 17682–41408 Bacitracin synthetase 3; BacC (Bacillus licheniformis) O68008 (42/61)
19 fusTE 41926–42549 Hypothetical protein (a/b hydrolase) (Gloeobacter violaceus) NP_924256 (47/66)
20 rrnA-16 s 43187–44711 16S ribosomal RNA gene (Paenibacillus polymyxa) EF532687 (99%)
21 rrnA-23 s 45016–47943 23S ribosomal RNA gene (Bacillus licheniformis) CP000002 (86%)actinomycetes (Balibar et al., 2005; Yin and Zabriskie, 2006).
Taken together, these findings suggest that either an external
racemase is involved in the transformation of thioester-bound
L-Ala to D-Ala, or that free D-Ala is directly selected and activated
by the A domain of FusA-M6, as was shown for the isolated ad-
enylation protein from leinamycin synthetase (Tang et al., 2007)
and strongly suggested for cyclosporin and HC-toxin biosynthe-
sis (Dittmann et al., 1994; Weber et al., 1994; Walton, 1987;
Scott-Craig et al., 1992).
Substrate Specificities of Adenylation Domains
By comparison with the amino acids lining the substrate-binding
pocket in the Phe-activating domain of gramicidin S synthetase
GrsA, a ‘‘nonribosomal code’’ specifying important residues in-
volved in substrate recognition by A domains has been defined
by two independent groups (Stachelhaus et al., 1999; Challis
et al., 2000). The corresponding amino acid residues were exam-
ined in the six A domains of FusA, and the substrate specificity of
each A domain was predicted (Table 2). The A domain in the first
module (FusA-A1) incorporating L-Thr and in the fourth module
(FusA-A4) incorporating D-allo-Thr both share the same signa-
ture sequence as the Thr-activating domain from fengycin syn-
thetase (FenD, GenBank accession number CAA09819). The
substrate-recognition sequence of FusA-A2 is most similar to
the Val-activating A domain from surfactin synthetase (SrfA-B,
GenBank accession number BAA08983), which also activates
Ile to a lesser extent (Elsner et al., 1997). The incorporation of
D-Val, D-Ile, or D-allo-Ile as substrates at this position in fusarici-
dins indicates an even broader substrate specificity, possibly
due to substitutions of Ile299/Leu and Gly322/Cys in FusA-Chemistry & Biology 15,A2 compared to SrfA-B. FusA-A3 contains a signature sequence
most closely resembling the 3-hydroxy-L-Tyr-activating domain
from chloroeremomycin synthetase (CepB, GenBank accession
number CAA11795). However, considerable similarity to the
Phe-activating domains from TycA and GrsA synthetases (Gen-
Bank accession numbers AAC45928 and CAA33603, respec-
tively) was also noted, which may explain the overall relaxed
specificity toward the aromatic and hydrophobic amino acid res-
idues seen at this position in the fusaricidin variants. The speci-
ficity code of FusA-A5 matches that of the Asn-activating A do-
main from tyrocidine synthetase (TycC, GenBank accession
number AAC45930). Replacement of D-Asn by D-Gln at the fifth
position in several fusaricidin variants indicates that this conser-
vative substitution is tolerated by the corresponding A domain.
The amino acid substrate for FusA-A6 cannot be predicted be-
cause its signature sequence shows no similarity to A domains
with assigned specificities, including those activating L- and
D-Ala (Figure 4). With the exception of FusA-M6, the predicted
substrates for the A domains of each module of fusaricidin syn-
thetase are consistent with the residues actually found at the
respective positions of the fusaricidin peptides.
In order to determine the substrate specificity of FusA-A6,
a DNA fragment corresponding to the A domain of FusA-M6
was amplified from fosmid 6D11 and was cloned into pET-19b.
Based on previously described A domain borders (Mootz and
Marahiel, 1997), the N-terminal end of the FusA-A6 domain
was set at 101 aa upstream from the core motif A2 (LKAGGA),
and the C-terminal end was set at 17 aa upstream from the
core motif T (LGGHS). After expression in E. coli, a soluble pro-
tein with a molecular mass of 64 kDa was obtained and purified118–127, February 2008 ª2008 Elsevier Ltd All rights reserved 121
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Fusaricidin Biosynthesis in P. polymyxaFigure 3. Comparison of the Conserved Core Motifs within Condensation Domains of FusA
Alternative amino acids at a particular position are indicated. The N-terminal C domains (CNs) of surfactin synthetase SrfA-A (Bacillus subtilis, GenBank accession
number BAA02522), daptomycin synthetase DptA (Streptomyces roseosporus, accession number AAX31557), and arthrofactin synthetase ArfA (Pseudomonas
sp. MIS38, accession number BAC67534) are shown in comparison to the CN of FusA. CL and CD domains of FusA represent condensation domains following
modules activating L- and D-amino acid residues, respectively. Shading indicates identity with the consensus sequence. The C domains in each peptide synthe-
tase are numbered according to their order in the protein.by Ni2+-affinity chromatography (Figure 5A). Enzymatic activity
of the purified recombinant FusA-A6 domain was determined
by an ATP-PPi exchange assay with various amino acids as sub-
strate. From the results obtained (Figure 5B), it was evident that
FusA-A6 activates D-Ala, with very low tolerance for L-Ala (less
than 1% of D-Ala), or any of a variety of amino acids, including
both L- and D-isomers (1%–4% of D-Ala). In previous studies of
cyclosporin and HC-toxin synthetases (Dittmann et al., 1994;
Weber et al., 1994; Walton, 1987; Scott-Craig et al., 1992), the
specificity for D-Ala activation by respective A domains was first
predicted based on the colinearity rule of NRPSs and then con-
firmed by showing direct incorporation of D-Ala by using native
NRPS proteins isolated from the producer fungi (Walton, 1987;
Cheng and Walton, 2000; Zocher et al., 1986). In contrast, direct
activation of D-Ala was demonstrated by using a recombinant
adenylation protein for leinamycin biosynthesis in S. altoooliva-122 Chemistry & Biology 15, 118–127, February 2008 ª2008 Elsevierceus (Tang et al., 2007); however, this is an unusual system in
which the D-Ala residue is incorporated into a hybrid peptide/pol-
yketide by an isolated adenylation protein rather than an NRPS
module.
The data from the present study show that the recombinant A
domain frommodule six of fusaricidin synthetase recognizes and
activates D-Ala as its substrate. To our knowledge, this repre-
sents the first example of a typical NRPS of prokaryotic origin
in which direct activation of a D-amino acid was observed. Ala-
specific A domains, whether for L- or D-isomers, show relatively
weak similarity. However, since the side chain of D-Ala might
be expected to extend toward the opposite face of the amino
acid-binding pocket compared to L-Ala, it is not clear that the
signature amino acids that define the nonribosomal code in A
domains have any relevance for D-isomers. Furthermore, the
small size of the Ala side chain may allow greater variability inTable 2. Amino Acid Residues Lining the Substrate-Binding Pockets of Adenylation Domains in Fusaricidin Synthetase
Adenylation
Domain
Residue Positions Involved in Substrate Recognitiona Predicted
Substrate Corresponding Residue in Fusaricidin235 236 239 278 299 301 322 330 331
FusA-A1 D F W N I G M V H Thr L-Thr
FusA-A2 D A F W L G C T F Val D-Val, D-allo-Ile, or D-Ile
FusA-A3 D A S T L A G V C 3H-Tyrb L-Tyr, L-Phe, L-Val, L-Ile, or L-allo-Ile
FusA-A4 D F W N I G M V H Thr D-allo-Thr
FusA-A5 D L T K I G E V G Asn D-Asn or D-Gln
FusA-A6 D F P N F C I V Y *c D-Ala
a Lys517 was not included because it is conserved in all six A domains.
b 3H-Tyr represents 3-hydroxy-L-tyrosine.
c * represents no match.Ltd All rights reserved
Chemistry & Biology
Fusaricidin Biosynthesis in P. polymyxaFigure 4. Alignment of the Amino Acid Sequences in Core Motifs A4 and A5 of FusA-A6 with Those of Other A Domains Known to Activate
L- or D-Ala
Deduced specificity-conferring residues are shaded light gray. Conservedmotif sequences A4 and A5 are underlined. Structural anchor residues are shaded dark
gray. Abbreviations for proteins are as follows: Cssa, cyclosporin synthetase (Tolypocladium inflatum, accession number Z28383); Hts, HC-toxin synthetase (C.
carbonum, accession number M98024); LnmQ, leinamycin synthetase (Streptomyces atroolivaceus, accession number AF484556); DltA, d-alanine-d-alanyl car-
rier protein ligase (Bacillus subtilis, accession number NP_391729.1); Cpps, d-lysergyl peptide synthetase (Claviceps purpurea, accession number CAB39315);
SafB, saframycin Mx1 synthetase B (Myxococcus xanthus, accession number YP_632693). The A domains in each peptide synthetase are numbered according
to their module order in the protein.the residues lining an Ala-binding pocket to be tolerated (Challis
et al., 2000). Interestingly, in each case in which direct activation
of a D-amino acid has been shown, the residue in question is
D-Ala. This allowable variability apparently can extend to accom-
modate the two chiral forms of Ala, whereas accommodating dif-
ferent chiral forms of larger amino acids may require so greatChemistry & Biology 15,a variation in sequence that A domain function would be com-
promised. Whereas the cyclosporin and HC-toxin biosynthetic
gene clusters each encode a distinct alanine racemase catalyz-
ing conversion of L- to D-Ala (Hoffmann et al., 1994; Cheng and
Walton, 2000), an alanine racemase specific for the fus cluster
was not encountered, nor was one reported for the leinamycin118–127, February 2008 ª2008 Elsevier Ltd All rights reserved 123
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Fusaricidin Biosynthesis in P. polymyxasystem (Tang et al., 2007). However, alanine racemases are
widely present in bacteria, where they provide D-Ala, essential
for cell wall synthesis.
Figure 5. Analysis of His-Tagged Recombi-
nant FusA-A6 Protein
(A) SDS-PAGE analysis of recombinant FusA-A6
protein. Lane 1, prestained protein ladder; lane
2, whole-cell extract obtained before IPTG induc-
tion; lane 3, whole-cell extract obtained after a 4 hr
induction with IPTG; lane 4, protein purified by
Ni2+-affinity chromatography.
(B) Relative activities of purified FusA-A6 protein
for various amino acid substrates determined by
using the ATP-PPi exchange assay. The control
reaction without amino acids was subtracted
from all reactions with amino acid substrates.
amino acid with the modified fatty acid
is presumably catalyzed by the initial C
domain in the first module of FusA. Addi-
tional studies are needed to clarify the
catalytic roles of the fatty acid and amino
acid biosynthetic genes upstream of fusA in fusaricidin biosyn-
thesis.N-Terminal Lipidation of Fusaricidins
Fusaricidins belong to a group of nonribosomal peptides that are
modified at the N terminus with a fatty acid. The lipid side chains
of lipopeptide antibiotics are believed to play an important role in
their interactions with their cellular target, i.e., cell membranes.
The predicted gene products of six ORFs (fusB, fusC, fusD,
fusE, fusF, and fusG) upstream of fusA show homology to en-
zymes involved in fatty acid or amino acid synthesis (Table 1)
and, accordingly, are likely involved in the synthesis and/or mod-
ification and activation of a fatty acid precursor for attachment to
the amino group of the N-terminal L-Thr residue of fusaricidin.
The acyl-CoA ligase encoded by fusF may begin the process
of lipid side chain synthesis by coupling coenzyme A (CoA) to
an acyl group, perhaps arising from primary metabolism or gen-
erated by the action of the FusD gene product. The resulting CoA
derivative would then be transferred to an acyl carrier protein
(ACP) for elongation by the fusB, fusC, and fusG gene products,
although no gene encoding an ACP-like protein was found in the
fus cluster. Possibly, an ACP from fatty acid biosynthesis or from
some other NRP or polyketide gene cluster fills this need in fusar-
icidin biosynthesis. Similarly, there is no obvious candidate gene
in the fus cluster to provide a ketoreductase function during fatty
acid biosynthesis, unless the aldehyde dehydrogenase encoded
by fusE fulfills this role. Rather than starting the process of side
chain synthesis, it is also possible that FusF ends the process
by activating the fully formed lipid side chain to a CoA derivative
before transfer to the initial C domain of FusA.
During lipid side chain synthesis, a b-OH group must be pre-
served or introduced into the growing fatty acid chain, and, ulti-
mately, the activated fatty acid must be further modified by
addition of a guanidino group. Alternatively, perhaps an arginine
residue is deaminated to 5-guanidino pentanoic acid, then acti-
vated and transferred to ACP for elongation by a process anal-
ogous to fatty acid biosynthesis. Acylation of the N-terminal124 Chemistry & Biology 15, 118–127, February 2008 ª2008 ElsevieBoundaries of the fus Cluster
Downstream of fusA and oriented in the opposite orientation,
a 624 bp ORF encoding a putative protein of 207 amino acids
was detected (Figure 2A). This gene product shows the greatest
similarity to proteins of the a/b hydrolase fold family (45% iden-
tity) and has one conserved GxSxG motif typical of thioes-
terases. Therefore, we designated this ORF fusTE, although it
shows no similarity to genes encoding type II thioesterases
from other NRPS gene clusters. It also shows no significant sim-
ilarity to the C-terminal TE domain of FusA, but it may catalyze
hydrolysis of acyl or aminoacyl groups inappropriately attached
to the 40-PP cofactors of fusaricidin synthetase, as has been
demonstrated for other type II thioesterases (Schwarzer et al.,
2002). Alternatively, FusTE may function as an acyltransferase
for transfer of the fatty acid of fusaricidin onto the first condensa-
tionmodule of FusA, as has been demonstrated for SrfD, the type
II thioesterase of surfactin biosynthesis (Steller et al., 2004). DNA
sequence further upstream of fusTE showed 99% identity to a
P. polymyxa 16S rRNA gene, and beyond that a 23S rRNA
gene is apparent (Table 1). Therefore, fusTE was assigned as
the 30 boundary of the fusA gene cluster even though no gene-
disruption studies were conducted to confirm its involvement.
About 10 kb of DNA sequence upstream of fusG was also ex-
amined in order to identify additional genes involved in fusarici-
din production (Figure 2A). The next ORF (ymcC) upstream of
fusG encodes a protein product of 177 aa with similarity to
YmcC (a protein with unassigned function) from various species.
The counterpart of ymcC in the B. subtilis 168 genome precedes
a cluster of putative polyketide synthase genes. In order to deter-
mine whether ymcC plays a role in fusaricidin biosynthesis,
a ymcC mutant was created by using a previously described
PCR-targeting mutagenesis method (Li et al., 2007). The result-
ing ymcCmutant was assessed for fusaricidin production by bio-
assay of culture extracts against the indicator fungus L. macu-
lans, but fusaricidin production was unchanged compared to
the wild-type (data not shown). Another ORF oriented in ther Ltd All rights reserved
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stream. The predicted gene product of 445 aa shares sequence
similarity with potassium-uptake transporter proteins and sowas
designated ktp. However, the PKB1 mutant in which ktp was re-
placed by an antibiotic-resistance cassette also produced wild-
type levels of fusaricidins, thus indicating that the gene product
of ktp is not required for export of, or resistance to, fusaricidins.
In the sequenced region further upstream from ktp, a variety of
ORFs was encountered, but none encoded functions obviously
related to fusaricidin biosynthesis (Table 1). Therefore, the 50
boundary of the fus cluster is likely defined by fusG.
SIGNIFICANCE
Thegenecluster for productionof fusaricidin-type antifungal
antibioticshasbeenclonedandcharacterized fromPaeniba-
cillus polymyxa PKB1, a potential biocontrol agent for black-
leg disease of canola. Other than fusA, encoding the peptide
synthetase, and genes associated with the synthesis and at-
tachment of theN-terminal guanidino-lipid, nogenes for reg-
ulation, resistance, or transport were found in the cluster.
Genes encoding regulators and ABC-type transporters are
frequently found in gene clusters for lipopeptides, although
their involvement in peptide production has not always
been established (Roongsawang et al., 2003; Miao et al.,
2005; Mootz and Marahiel, 1997). In fusaricidin production,
these functions must be provided by genes from elsewhere
on the chromosome. D-amino acid residues are important el-
ements of nonribosomally produced peptides. Examination
of the fusaricidin gene cluster revealed that two strategies
for D-amino acid incorporation are employed by fusaricidin
synthetase. Incorporation of D-amino acids in the second,
fourth, and fifth positions of fusaricidins ismediated by E do-
mains in the corresponding modules, whereas no E domain
is found in the sixth module corresponding to D-Ala. The
sixth A domain of FusA exhibits stereospecificity for D-Ala,
a characteristic only reported previously in two eukaryotic
NRPSs and one prokaryotic hybrid peptide/polyketide syn-
thetase. Cloning of the fusaricidin NRPS gene makes it pos-
sible to consider genetic manipulation to increase the anti-
fungal activity of the PKB1 strain. Fusaricidin is a mixture
of at least 12 depsipeptides, resulting from the relaxed sub-
strate specificity of fusaricidin synthetase. Alterations of A
domain selectivity by mutation of specificity-conferring res-
idues (Eppelmann et al., 2002; Uguru et al., 2004)maymake it
possible to narrow the substrate specificities of the relevant
FusAmodules, thereby increasing yields of fusaricidin A and
B, variants associated with the greatest antifungal activity
(Beatty and Jensen, 2002).
EXPERIMENTAL PROCEDURES
Strains and Growth Conditions
Media for growth of P. polymyxa PKB1 and Escherichia coli have been previ-
ously described (Li et al., 2007). E. coliDH5a and XL1-Blue were used for prep-
aration of recombinant plasmids. E. coli strain E. cloni Replicator (Lucigen,
Middleton, WI) was used as the host for the fosmid genomic library and prep-
aration of fosmid DNA. High-level production of recombinant proteins was per-
formed in E. coli BL21(DE3).Chemistry & Biology 15,DNA Manipulations
Chromosomal DNA from P. polymyxa was isolated as previously described (Li
et al., 2007). The P. polymyxa ymcC and ktpmutants were constructed by us-
ing the previously described PCR-targeted mutagenesis technique (Li et al.,
2007). The PCR primers used to amplify the Aprar Cmr oriT disruption cassette
are as follows: ymcC mutant, JRL42-RD (50-AAATACCAATTTCTAATTTGA
AAGGAATCATCTATTATGATTCCGGGGATCCGTCGACC-30) and JRL43-RD
(50-ACCAGCCAGATATCATCTAAGTGTAAGTCTTAACCTTTATGTAGGCTGGA
GCTGCTTC-30); ktpmutant, JRL31-RD (50-CTCTTTTTCATAAGAACGGATGGA
GAGAATACTCTAATGATTCCGGGGATCCGTCGACC-30) and JRL32-RD (50-G
CTAATCAGCACGGGTACATCCTTTTTATAGATACATTATGTAGGCTGGAGCTG
CTTC-30). The lRed recombination plasmid pKD46 and fosmid 4G9were used
to prepare the disruption constructs. All other DNAmanipulations were carried
out according to standard techniques (Sambrook et al., 1989).
Cloning and Sequencing of the fus Gene Cluster
A genomic library ofP. polymyxa PKB1was constructedwith the fosmid vector
pSMART-FOS (Lucigen, Middleton, WI), by following the manufacturer’s
instruction. Chromosomal DNA from the PKB1 strain was partially digested
with Sau3AI and was size fractioned on a 0.8% low-melting-point agarose
gel. The region containing DNA fragments of 35–45 kb was excised and recov-
ered from the gel by agarase digestion. After precipitation with isopropanol,
the purified genomic DNA fragments were ligated with BamHI-digested, de-
phosphorylated pSMART-FOS vector at 16C for 16 hr. The resulting ligation
mixture was packaged in vitro with Gigapack III XL (Stratagene) and then intro-
duced into the E. cloni Replicator cells by transfection. A total of 550 clones
were transferred onto a Hybond-N nylon membrane (Amersham Pharmacia
Biotech, Buckinghamshire, UK) and screened according to themanufacturer’s
protocols. The nucleotide sequences of positive fosmid inserts were deter-
mined in part by SeqWright DNA Technology Services (Houston, TX). Gaps
were closed by direct sequencing of fosmid DNA, carried out by the Molecular
Biology Facility at University of Alberta. GeneTools 2.0 and PepTool 1.0 (Bio-
Tools, Inc., Edmonton, Canada) were used for analysis of the DNA sequence
and the amino acid sequence, respectively. Nucleotide and amino acid se-
quence similarity searches were performed by using the online program
BLAST (http://www.ncbi.nlm.nih.gov/BLAST/).
Overproduction and Purification of the His-Tagged Adenylation
Domain Corresponding to D-Ala
A DNA fragment encoding the sixth A domain (FusA-A6) was amplified from
fosmid 6D11 by using the Expand High-Fidelity PCR system (Roche, Man-
nheim, Germany) with primers JRL37 (50-TAAGGATCCCCAAATCTGCGCTAG
TTCTAC-30) and JRL38 (50-CTGCATATGCGTATTGATGAGCTGGAGTTGA-30)
(restriction sites are underlined). PCR products were first cloned into pCR2.1-
TOPO (Invitrogen, Carlsbad, CA), and then excised as NdeI-BamHI fragments
and ligated into a similarly digested pET-19b (Novagen, Darmstadt, Germany).
E. coli BL21(DE3) cells were then transformed with the recombinant expres-
sion plasmid, and cultures yielded an N-terminally His-tagged protein when
grown in Luria-Bertani medium to an OD600 of 0.6, followed by induction
with 1 mM isopropyl-b-D-thiogalactopyranoside (IPTG) and then 4 hr of growth
at 22C. Purification of soluble His-tagged FusA-A6 protein was performed by
Ni2+-affinity chromatography (QIAGEN) according to the manufacture’s proto-
col. Purified protein was then desalted into assay buffer (50 mM sodium phos-
phate [pH 8.0], 10 mM MgCl2, 2 mM dithiothreitol, 1 mM EDTA) by using
a NAP-5 column (Amersham Pharmacia Biotech, Uppsala, Sweden). The
purity of the recombinant protein was checked by sodium dodecyl sulfate
(SDS)-polyacrylamide gel electrophoresis with Coomassie Brilliant blue stain-
ing. Protein concentration was determined by using a calculated 3280 for
purified FusA-A6 of 65,375 M1cm1.
ATP-PPi Exchange Assay
The amino acid specificity of purified recombinant FusA-A6 protein was deter-
mined by using an ATP-PPi exchange assay, performed as previously de-
scribed (Mootz and Marahiel, 1997), with minor modifications. Reaction mix-
tures contained 50 mM sodium phosphate (pH 8.0), 2 mM MgCl2, 2 mM
dithiothreitol, 2 mM ATP, 1 mM amino acid substrate, 0.2 mCi tetrasodium
[32P]-pyrophosphate (Perkin Elmer, Boston, MA) and 0.1 mM tetrasodium py-
rophosphate. Reactions were initiated by the addition of recombinant FusA-A6118–127, February 2008 ª2008 Elsevier Ltd All rights reserved 125
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Fusaricidin Biosynthesis in P. polymyxaprotein to a final concentration of 250 nM in a total volume of 100 ml. After in-
cubation at 37C for 15min, reactions were stopped by adding 0.5 ml termina-
tionmixture (1.2% [w/v] activated charcoal, 0.1M tetrasodiumpyrophosphate,
and 0.5 M HClO4). The charcoal was sedimented by centrifugation and
washed once with 1 ml H2O. The radioactivity bound to the charcoal was de-
termined by liquid scintillation counting.
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The nucleotide sequence of the fusaricidin biosynthetic gene cluster and flank-
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Note Added in Proof
An article has appeared recently describing the sequence of a similar fusarici-
din synthetase-encoding gene from another strain of Paenibacillus polymyxa.
See: Choi, S.K., Park, S.Y., Kim, R., Lee, C.H., Kim, J.F. and Park, S.H. (2008).
Identification and functional analysis of the fusaricidin biosynthetic gene of
Paenibacillus polymyxa E681. Biochem. Biophys. Res. Commun. 365, 89–95.118–127, February 2008 ª2008 Elsevier Ltd All rights reserved 127
